Towa Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3623150004
JPY
3,995.00
125 (3.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
73,589.00
65,327.00
65,149.00
65,857.00
70,333.00
60,838.00
62,566.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
73,589.00
65,327.00
65,149.00
65,857.00
70,333.00
60,838.00
62,566.00
Raw Material Cost
45,674.00
41,796.00
41,474.00
41,872.00
44,503.00
39,267.00
39,223.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
532.00
609.00
540.00
465.00
386.00
445.00
331.00
Selling and Distribution Expenses
18,867.00
18,294.00
18,468.00
15,842.00
12,440.00
9,652.00
17,340.00
Other Expenses
-53.20
-60.90
-54.00
304.70
490.60
663.30
-0.10
Total Expenditure (Excl Depreciation)
64,541.00
60,090.00
59,942.00
61,226.00
62,235.00
55,997.00
56,893.00
Operating Profit (PBDIT) excl Other Income
9048
5237
5207
4631
8098
4841
5673
Other Income
455.00
358.00
747.00
813.00
868.00
805.00
1,018.00
Operating Profit (PBDIT)
15,383.00
11,252.00
11,203.00
10,781.00
14,128.00
10,511.00
11,426.00
Interest
532.00
609.00
540.00
465.00
386.00
445.00
331.00
Exceptional Items
3,023.00
3,007.00
-1,452.00
-483.00
2,952.00
-3,483.00
2,223.00
Gross Profit (PBDT)
27,915.00
23,531.00
23,675.00
23,985.00
25,830.00
21,571.00
23,343.00
Depreciation
5,880.00
5,657.00
5,249.00
5,337.00
5,162.00
4,865.00
4,735.00
Profit Before Tax
11,995.00
7,995.00
3,960.00
4,499.00
11,531.00
1,716.00
8,584.00
Tax
3,127.00
2,294.00
1,447.00
136.00
3,463.00
655.00
3,089.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
8,868.00
5,701.00
2,513.00
4,362.00
8,069.00
1,060.00
5,495.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
8,868.00
5,701.00
2,513.00
4,362.00
8,069.00
1,060.00
5,495.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8,868.00
5,701.00
2,513.00
4,362.00
8,069.00
1,060.00
5,495.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,89,689.00
1,79,863.00
1,72,721.00
1,71,625.00
1,69,023.00
1,59,110.00
1,62,992.00
Earnings per share (EPS)
180.14
115.81
51.05
88.61
163.91
21.53
111.64
Diluted Earnings per share
180.14
115.81
51.05
88.61
163.91
21.53
111.64
Operating Profit Margin (Excl OI)
12.3%
8.02%
7.99%
7.03%
11.51%
7.96%
9.07%
Gross Profit Margin
24.29%
20.9%
14.14%
14.94%
23.73%
10.82%
21.29%
PAT Margin
12.05%
8.73%
3.86%
6.62%
11.47%
1.74%
8.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 12.65% vs 0.27% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 55.55% vs 126.86% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 37.03% vs 4.19% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -12.64% vs 12.78% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Towa Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
73,589.00
18,261.00
55,328.00
302.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
73,589.00
18,261.00
55,328.00
302.98%
Raw Material Cost
45,674.00
9,009.00
36,665.00
406.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
532.00
11.00
521.00
4,736.36%
Selling and Distribution Expenses
18,867.00
4,927.00
13,940.00
282.93%
Other Expenses
-53.20
396.20
-449.40
-113.43%
Total Expenditure (Excl Depreciation)
64,541.00
17,909.00
46,632.00
260.38%
Operating Profit (PBDIT) excl Other Income
9,048.00
352.00
8,696.00
2,470.45%
Other Income
455.00
219.00
236.00
107.76%
Operating Profit (PBDIT)
15,383.00
1,408.00
13,975.00
992.54%
Interest
532.00
11.00
521.00
4,736.36%
Exceptional Items
3,023.00
28.00
2,995.00
10,696.43%
Gross Profit (PBDT)
27,915.00
9,252.00
18,663.00
201.72%
Depreciation
5,880.00
837.00
5,043.00
602.51%
Profit Before Tax
11,995.00
587.00
11,408.00
1,943.44%
Tax
3,127.00
182.00
2,945.00
1,618.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
8,868.00
406.00
8,462.00
2,084.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
8,868.00
406.00
8,462.00
2,084.24%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8,868.00
406.00
8,462.00
2,084.24%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,89,689.00
1,45,808.00
43,881.00
30.10%
Earnings per share (EPS)
180.14
10.72
169.42
1,580.41%
Diluted Earnings per share
180.14
10.72
169.42
1,580.41%
Operating Profit Margin (Excl OI)
12.30%
1.93%
0.00
10.37%
Gross Profit Margin
24.29%
7.80%
0.00
16.49%
PAT Margin
12.05%
2.22%
0.00
9.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7,358.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 12.65% vs 0.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.63% vs 15.43% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 886.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 55.55% vs 126.86% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 9.90% vs 76.76% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,492.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 37.03% vs 4.19% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.58% vs 23.25% in Dec 2024

Quarterly - Interest
Interest 53.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -12.64% vs 12.78% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 37.82% vs 47.33% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.30%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024